Drugs that contain Naloxone Hydrochloride; Oxycodone Hydrochloride

1. Drug name - TARGINIQ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9073933 PURDUE PHARMA LP Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Mar, 2025

(2 years from now)

US9522919 PURDUE PHARMA LP Oxycodone compositions
Mar, 2025

(2 years from now)

CN101812065B PURDUE PHARMA LP Contains Less Than 25 Ppm Ppm Of 14-Hydroxymethyl Codeine To Oxycodone Hydrochloride Ketone Can Be Ketone
Mar, 2025

(2 years from now)

CN1960994A PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102838607B PURDUE PHARMA LP Preparation Contains Less Than 25 Ppm Of 14-Hydroxide Can Be Oxycodone Method By Hydrochloric Acid
Mar, 2025

(2 years from now)

CN1960994B PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN101812065A PURDUE PHARMA LP A Method For Preparing Oxycodone Hydrochloride Composition With Less Than 25Ppm Of 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102127086A PURDUE PHARMA LP Method For Preparing Pancodine Composition Containing Less Than 25 Ppm Of 14-Oxycodone
Mar, 2025

(2 years from now)

CN102887903A PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102127086B PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102838607A PURDUE PHARMA LP Method For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm Of 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

CN102887903B PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2426132B1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Compositions Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2305683A1 PURDUE PHARMA LP Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2305683B8 PURDUE PHARMA LP Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP1730151B1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2316837B1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP1730151A4 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP1730151B2 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2316837A1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2319846A1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2319846B1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2305683B1 PURDUE PHARMA LP Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP1730151A1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

EP2426132A1 PURDUE PHARMA LP Process For Preparing Oxycodone Hydrochloride Compositions Having Less Than 25Ppm 14-Hydroxycodeinone
Mar, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8846090 PURDUE PHARMA LP Matrix for sustained, invariant and independent release of active compounds Apr, 2023

(6 months from now)

US8846091 PURDUE PHARMA LP Matrix for sustained, invariant and independent release of active compounds Apr, 2023

(6 months from now)

US9555000 PURDUE PHARMA LP Pharmaceutical preparation containing oxycodone and naloxone Apr, 2023

(6 months from now)

US9907793 PURDUE PHARMA LP Pharmaceutical preparation containing oxycodone and naloxone Apr, 2023

(6 months from now)

Treatment: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
5MG;10MG TABLET, EXTENDED RELEASE;ORAL Discontinued
10MG;20MG TABLET, EXTENDED RELEASE;ORAL Discontinued
20MG;40MG TABLET, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.